Second, the APP/PS1ΔE9 model, while widely used and well-characterized for studying amyloid pathology, primarily recapitulates the amyloid-centric aspects of Alzheimer’s disease and does not fully exhibit tau pathology, extensive neurodegeneration, or the full spectrum of pathological features observed in human AD. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.